ITRM vs TFC · rev $390.0K vs rev $24.54B
Iterum Therapeutics PLC (ITRM) versus TFC (TFC) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
TFC (TFC) common stock.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported TFC revenue for 2025-12-31 was $24.54B. Net income was $5.31B. Revenue was down 2.1% from 2024-12-31 to 2025-12-31. TFC currently screens at market cap $0.
ITRM currently screens at market cap $38.6M. TFC currently screens at market cap $0.
Not investment advice. Open the ITRM and TFC stock pages for the full models.
Not investment advice.